Kasugamycin Bactericide 2% SL 2% WP

Item	Details
Active Ingredient	Kasugamycin
Product Type	Antibiotic bactericide / fungicide
Mode of Action	Group 24, protein synthesis inhibition
Available Formulations	2% SL, 2% WP
Main Disease Direction	Bacterial diseases and approved fungal disease programs
Crop Direction	Rice, vegetables, fruit crops, and approved crop programs
Use Positioning	Preventive and early-stage disease management, label-dependent
Supply Support	Private label packaging, documents, and batch quality support

What Is Kasugamycin?

Kasugamycin is an antibiotic active ingredient used for crop disease management.

Its key value is bacterial disease direction. In some approved crop programs, it may also be positioned for specific fungal disease management. The final disease scope depends on local registration and approved label instructions.

Kasugamycin should be positioned as a professional disease management product, not as a broad universal fungicide. It is suitable for markets that need a bactericide product line, rice disease programs, vegetable disease programs, or approved fruit crop disease solutions.

At POMAIS, we position Kasugamycin carefully according to target market, crop direction, disease claim, registration format, and formulation requirement.

How Kasugamycin Works

Kasugamycin works by inhibiting protein synthesis in sensitive pathogens.

This mode of action supports its use in bacterial disease management programs and approved fungal disease directions. It is different from multi-site contact fungicides such as Captan or Chlorothalonil. It is also different from copper-based bactericide products.

Kasugamycin should be described as:

• an antibiotic bactericide and fungicide active ingredient
• a Group 24 disease management product
• a product for bacterial disease direction where approved
• a formulation option for professional crop disease programs

Kasugamycin should not be described as:

• a universal fungicide
• a product for all crop diseases
• a guaranteed disease control solution
• a resistance-free product
• a replacement for all bactericide or fungicide programs

Final use direction must follow the approved local label.

Kasugamycin Mode of Action

Kasugamycin belongs to Group 24.

Its mode of action is related to protein synthesis inhibition. This makes it different from protectant multi-site fungicides and copper-based bactericides.

For product positioning, this gives Kasugamycin clear value in bacterial disease management and approved fungal disease programs. However, repeated reliance on one mode of action should be avoided.

Kasugamycin use should follow local resistance management guidance, approved crop programs, label instructions, and integrated disease management principles.

Main Crop and Disease Positioning

Kasugamycin is commonly positioned for bacterial disease directions and approved fungal disease programs.

Crop / Market Direction	Disease Program Positioning
Rice	Rice blast and approved disease programs
Tomatoes	Bacterial spot, leaf mold, and approved disease programs
Peppers	Bacterial spot direction where locally approved
Fruit crops	Fire blight, bacterial disease, or approved crop disease programs
Vegetables	Bacterial disease management direction where approved
Approved crop programs	Final crop and disease scope must follow local label instructions

Disease claims must be controlled carefully. Kasugamycin should not be presented as a universal disease control product.

Final crop scope, disease spectrum, timing, dose, interval, and application method must follow local registration and approved label instructions.

Available Formulations: Kasugamycin 2% SL and 2% WP

POMAIS supplies Kasugamycin in two main formulation options:

• Kasugamycin 2% SL
• Kasugamycin 2% WP

Both products use Kasugamycin as the active ingredient. The main difference is formulation type, packaging direction, market positioning, and local registration preference.

The right option depends on your target market, registration format, product line strategy, packaging plan, and local distribution channel.

Kasugamycin 2% SL Formulation Features

Kasugamycin 2% SL is a soluble liquid formulation.

SL means soluble liquid. This formulation is suitable for markets that prefer liquid bactericide and fungicide products, bottle supply, drum supply, carton supply, and private label liquid packaging.

Key formulation value:

• Soluble liquid formulation
• 2% active ingredient content
• Suitable for bottle and drum supply
• Practical for liquid disease management product lines
• Suitable for private label liquid packaging
• Clear specification for registration and procurement comparison

For this formulation, we focus on liquid appearance, solubility, physical stability, container sealing, and leakage control before shipment.

Kasugamycin 2% SL should not be described as automatically better or faster than Kasugamycin 2% WP. Field performance depends on approved label use, formulation quality, disease pressure, crop condition, timing, and application program.

Kasugamycin 2% WP Formulation Features

Kasugamycin 2% WP is a wettable powder formulation.

WP means wettable powder. This dry powder formulation is suitable for markets that prefer sachets, bags, cartons, export cartons, and powder disease management product channels.

Key formulation value:

• Wettable powder formulation
• 2% active ingredient content
• Dry powder product format
• Suitable for sachets, bags, cartons, and export cartons
• Practical for powder bactericide and fungicide product lines
• Suitable for private label powder packaging
• Clear specification for registration and procurement documents

For this formulation, we focus on powder appearance, wetting performance, suspension attention, moisture control, package sealing, and carton protection.

Kasugamycin 2% WP should not be described as a lower-quality option. It is a different formulation choice for markets that prefer wettable powder products.

Choosing the Right Kasugamycin Formulation for Your Market

Kasugamycin 2% SL and Kasugamycin 2% WP should be selected according to market need, not by a simple “better or worse” judgment.

Market Need	Suitable Option
Liquid formulation channel	Kasugamycin 2% SL
Bottle or drum supply	Kasugamycin 2% SL
Powder formulation channel	Kasugamycin 2% WP
Sachet, bag, or carton supply	Kasugamycin 2% WP
Private label bactericide supply	Both formulations
Registration-driven specification choice	Depends on local registration format
Flexible product line planning	Both formulations

The right choice depends on your target market, registration format, formulation preference, packaging plan, and local distribution channel.

Application Guidance

Use Kasugamycin only where locally approved.

General use principles:

• Follow the approved local label.
• Use only on registered crops and listed diseases.
• Position Kasugamycin for bacterial disease and approved fungal disease programs.
• Apply according to approved disease timing and crop program.
• Do not claim universal disease control.
• Do not use on crops or diseases not listed on the local label.
• Tank mix and compatibility must follow approved label instructions.
• Use as part of an integrated disease management program.
• Follow local rules for agricultural antibiotic products where applicable.

No specific dose, dilution rate, spray interval, application frequency, crop stage operation, or tank mix advice should be used without an approved local label.

Crop Safety and Use Boundary

Crop safety depends on crop species, variety, growth stage, weather, disease pressure, tank mix, application timing, formulation type, and approved label use.

Use only where Kasugamycin is locally approved. Registration status, crop scope, and disease claims may vary by destination market.

Kasugamycin should be positioned clearly.

It is:

• an antibiotic bactericide and fungicide active ingredient
• a Group 24 disease management product
• a product for bacterial disease direction where approved
• available in SL and WP formulations

It is not:

• a universal fungicide
• a product for all bacterial diseases
• a product for all fungal diseases
• a resistance-free product
• a product that can be used without label guidance
• a guarantee of complete disease control

Final crop scope and use boundary must follow local registration and approved label instructions.

Resistance Management

Kasugamycin belongs to Group 24.

Resistance management is important when using antibiotic-type disease management products. Repeated use of the same mode of action may increase selection pressure on less-sensitive pathogen populations.

Recommended program principles:

• Avoid repeated reliance on Kasugamycin alone.
• Rotate with other approved modes of action where locally allowed.
• Follow local resistance management guidance.
• Combine product use with crop hygiene and field management.
• Monitor disease development and control performance.
• Follow the approved local label.

Kasugamycin should not be described as resistance-proof or as a product that solves disease resistance alone.

Storage and Transport

Store Kasugamycin formulations in sealed original packaging.

General storage principles:

• Keep in a cool, dry, and ventilated place.
• Avoid moisture, direct sunlight, and high temperature.
• Keep away from food, feed, seed, and incompatible materials.
• Keep packages tightly closed before use.
• Protect bottles, drums, bags, cartons, and outer packing from damage.
• Follow SDS and local transport requirements.

For Kasugamycin 2% SL, quality attention should include liquid appearance, solubility, physical stability, bottle and drum sealing, leakage control, and carton protection.

For Kasugamycin 2% WP, quality attention should include powder appearance, wetting performance, suspension attention, moisture control, package sealing, and carton protection.

Packaging and Private Label Support

POMAIS supports private label packaging for both Kasugamycin 2% SL and Kasugamycin 2% WP.

For Kasugamycin 2% SL, packaging options may include:

• Bottles
• Drums
• Cartons
• Export cartons
• Private label liquid packaging

For Kasugamycin 2% WP, packaging options may include:

• Sachets
• Bags
• Cartons
• Export cartons
• Private label powder packaging

Available support may include:

• Customized private label packaging
• Multi-language label design
• Batch coding
• Carton marks
• Export packing
• Market-oriented pack size planning
• Label and carton design support
• Specification alignment for target markets

Packaging can be adjusted according to your target market, formulation preference, registration plan, and order requirements.

Document Support

POMAIS can provide document support for procurement, registration preparation, import communication, and shipment coordination.

Available documents may include:

• COA
• MSDS / SDS
• TDS
• Product specification
• Packing information
• Label reference
• Batch information
• Shipment documents

We can align the final document format with your import process, registration direction, private label project, and destination-market requirements.

Quality Control

Quality control for Kasugamycin formulations focuses on active ingredient content, formulation appearance, physical stability, packaging integrity, and shipment readiness.

For Kasugamycin 2% SL, key control points include:

• Active ingredient content check
• Liquid appearance review
• Solubility / physical stability attention
• Bottle and drum sealing inspection
• Leakage control before shipment
• Carton inspection
• Batch record management
• Shipment document review

For Kasugamycin 2% WP, key control points include:

• Active ingredient content check
• Powder appearance review
• Wetting / suspension attention
• Moisture attention
• Sachet or bag sealing inspection
• Carton inspection
• Batch record management
• Shipment document review

Each batch should be checked according to product specification, packaging requirements, and export requirements before shipment.

Need Related Disease Management Products?

Kasugamycin is suitable for bacterial disease direction and approved fungal disease programs where an antibiotic-type disease management product is required.

For a wider disease management portfolio, related products may be considered according to target crop, disease pressure, registration direction, and local market positioning.

Suggested internal links:

• fungicide formulations
• bactericide products for crop disease management
• Validamycin fungicide formulation
• copper bactericide formulation
• request a Kasugamycin supply quote

FAQ

What is Kasugamycin?

Kasugamycin is an antibiotic bactericide and fungicide active ingredient used in crop disease management programs where locally approved.

Is Kasugamycin mainly a bactericide or fungicide?

Kasugamycin is mainly positioned for bacterial disease direction. It may also support approved fungal disease programs depending on local registration and label instructions.

What is the mode of action of Kasugamycin?

Kasugamycin belongs to Group 24. Its mode of action is related to protein synthesis inhibition in sensitive pathogens.

What diseases is Kasugamycin used for?

Kasugamycin is positioned for bacterial diseases and approved fungal disease programs. Final disease claims must follow local registration and approved label instructions.

What crops can Kasugamycin be used on?

Common crop directions may include rice, vegetables, fruit crops, and approved crop programs. Final crop scope must follow the approved local label.

What is the difference between Kasugamycin 2% SL and 2% WP?

Kasugamycin 2% SL is a soluble liquid formulation. Kasugamycin 2% WP is a wettable powder formulation. The right choice depends on market positioning, registration format, packaging plan, and local distribution channel.

Is Kasugamycin 2% SL better than Kasugamycin 2% WP?

Not necessarily. Kasugamycin 2% SL fits liquid product channels, while Kasugamycin 2% WP fits powder product channels. Both options should be selected according to market and registration needs.

Can Kasugamycin be used repeatedly?

Repeated reliance on the same mode of action is not recommended. Kasugamycin should be used according to approved resistance management guidance and local label instructions.

Can POMAIS provide private label Kasugamycin formulations?

Yes. POMAIS can support private label packaging for Kasugamycin 2% SL and Kasugamycin 2% WP, including bottles, drums, sachets, bags, cartons, multi-language labels, batch coding, and export packing.

What documents can POMAIS provide?

POMAIS can support COA, MSDS/SDS, TDS, product specification, packing information, label reference, batch information, and shipment documents.

Why Choose POMAIS

At POMAIS, we support professional buyers who need clear product specifications, stable formulation supply, private label packaging, and export-ready documentation.

For Kasugamycin products, we can support both 2% SL and 2% WP formulation supply. Our service covers formulation communication, packaging planning, document preparation, batch quality control, and export coordination.

Our supply support is suitable for agricultural importers, distributors, registration companies, crop protection channels, and project-based agricultural procurement.

Partner with POMAIS for Kasugamycin Supply

If you are sourcing Kasugamycin in 2% SL or 2% WP formulation, we can support your project with product specification, private label packaging, document preparation, quality control, and export coordination.

Please send your destination country, target crop market, disease direction, formulation preference, packaging request, and expected order volume. Our team will provide a suitable supply proposal based on your procurement needs.